Dodge & Cox Astrazeneca PLC Transaction History

Dodge & Cox

$159 Billion
Q2 2024

A detailed history of Dodge & Cox transactions in Astrazeneca PLC stock. As of the latest transaction made, Dodge & Cox holds 149,785 shares of AZN stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

149,785

Previous 155,285 3.54%

Holding current value

$11.6 Million

Previous $10.5 Million 11.04%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $367,455 - $444,565	-5,500 Reduced 3.54%	149,785 $11.7 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $23,801 - $27,132	-390 Reduced 0.25%	155,285 $10.5 Million
Q4 2023 Feb 15, 2024	SELL	$61.89 - $69.28 $102,118 - $114,312	-1,650 Reduced 1.05%	155,675 $10.5 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $2.55 Million - $2.81 Million	-39,250 Reduced 19.97%	157,325 $10.7 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1.88 Million - $2.04 Million	-26,850 Reduced 12.02%	196,575 $14.1 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $5.36 Million - $6.08 Million	-84,900 Reduced 27.54%	223,425 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $4.23 Million - $5.5 Million	-78,040 Reduced 20.2%	308,325 $20.9 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $6.16 Million - $15.8 Million	-116,124 Reduced 23.11%	386,365 $21.2 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $18 Million - $21.7 Million	-304,337 Reduced 37.72%	502,489 $33.2 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $616,764 - $742,951	-11,069 Reduced 1.35%	806,826 $53.5 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.4 Million - $1.66 Million	-25,970 Reduced 3.08%	817,895 $47.6 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $1.68 Million - $1.83 Million	-30,161 Reduced 3.45%	843,865 $50.7 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $786,825 - $977,925	-16,250 Reduced 1.83%	874,026 $52.4 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $114 Million - $132 Million	-2,424,896 Reduced 73.15%	890,276 $44.3 Million
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $558 Million - $668 Million	-11,506,174 Reduced 77.63%	3,315,172 $166 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $210 Million - $242 Million	-3,954,417 Reduced 21.06%	14,821,346 $812 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $479 Million - $614 Million	-11,107,275 Reduced 37.17%	18,775,763 $993 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $325 Million - $441 Million	-8,591,892 Reduced 22.33%	29,883,038 $1.33 Billion
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $462 Million - $549 Million	-10,874,210 Reduced 22.04%	38,474,930 $1.92 Billion
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $488,581 - $553,733	12,178 Added 0.02%	49,349,140 $2.2 Billion
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $2.88 Million - $3.22 Million	-77,239 Reduced 0.16%	49,336,962 $2.04 Billion
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $3.63 Million - $4.4 Million	-102,200 Reduced 0.21%	49,414,201 $2 Billion
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $59.9 Million - $67.4 Million	-1,623,908 Reduced 3.18%	49,516,401 $1.88 Billion
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $56.8 Million - $64.9 Million	-1,634,500 Reduced 3.1%	51,140,309 $2.02 Billion
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $60.6 Million - $65 Million	-1,755,370 Reduced 3.22%	52,774,809 $1.85 Billion
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $66 Million - $73.3 Million	-2,000,800 Reduced 3.54%	54,530,179 $1.91 Billion
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $10.6 Million - $11.5 Million	330,801 Added 0.59%	56,530,979 $1.96 Billion
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $1.63 Billion - $1.91 Billion	56,200,178	56,200,178 $1.9 Billion

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account